Eager to be Healthy – Crystal Collins – Want to be Vegan

Listen to the Episode Below (36:06)

Crystal Collins is today’s guest on Eager to be Healthy.  We talk about juicing, veganism, and raising healthy kids in a divided home. 

Crystal Collins

Crystal Collins

Website:
http://naturalthrifty.com
 
What do you do to improve the health and happiness of others?
I encourage people to get healthier through one-on-one sessions, public speaking, and through my website and online presence. I’ve written several ebooks on the topic of healthier living, with a huge focus on green juicing. I encourage people to make small steps each week to change their health, because it’s not always about being extreme or obsessed with every little thing that we eat or do. It’s about the daily choice to do small things that add up to a huge difference.
Do you have a story or an adventure from becoming healthy?
Through simple diet changes into eating healthier foods and staying active, I dropped from a size 16 down to s size 4. I didn’t do an extreme diet or hardcore fitness regimen to change my life, and the simple eating and activity has made all the difference in keeping the weight off and maintaining a healthy lifestyle.
What are your interests and hobbies outside of wellness?
I’m a huge music and drama geek. I enjoy playing my guitar and singing. Aside from when I’m able to change someone’s health for the better, I never feel more fulfilled than when I’m on stage pouring out my heart in song. I most recently starred as Fiona in Shrek the Musical at the Rockmart Arts Center Theater.
What topics on the subject of improving health and increasing happiness can you talk about?
I can talk about fitness, healthier eating, juicing, smoothies, healthy beauty and skin care products, green home products, and raw clean eating.
Do you have products or services you wish to promote? If so what are they?
Sure! I’d love to promote my 21 day juicing challenge. http://naturalthrifty.com/21-day-juicing-challenge
Why do you feel your happy?
I’m happy because I live a whole health lifestyle. Toxins are everywhere: in food, in the air we breathe, in the water we drink, and in the people that we allow into our lives. Removing the toxins is empowering and opens our minds to a higher level of thinking and mental health. When we are healthy with the foods we put into our bodies, with our physical fitness, and surround ourselves with beautiful people then we find a deeper level of joy and happiness.

The post Eager to be Healthy – Crystal Collins – Want to be Vegan appeared first on Michael Eger – Health Coach.

Eager to be Healthy – Billy Ruggles – Link and Landmark

Listen to the Episode Below (28:10)

I met Billy Ruggles early in my transformation. Mr. Ruggles has his own health story. While living in Massachusetts, he trained at Ludlow’s Team Link.

Bill is the one responsible for introducing me to Landmark Education , opening my mind to creating a new reality.  

My friendship with Billy has helped me grow a lot.

I am blessed that he is my friend. 

Please enjoy the interview. 

And as always, if you like the show, please rate us on iTunes.

Billy Ruggles

Hawaiian Billy Ruggles

 

The post Eager to be Healthy – Billy Ruggles – Link and Landmark appeared first on Michael Eger – Health Coach.

Eager to be Healthy – Robert Jones – Single Dad Diaries

Listen to the Episode Below (30:47)

Adversity is one of life’s best teaching skills.  Robert Jones experienced plenty. From dealing with his divorce, to battling for custody of his son, to just raising him into a good man.

We talk about how he survived the process, how seeking help helped him, what values he wants to give his son, and how to cook for a small family. 

Robert Jones and his son

Robert Jones and his son

The post Eager to be Healthy – Robert Jones – Single Dad Diaries appeared first on Michael Eger – Health Coach.

Eager to be Healthy – Jenny Drescher – Fear, Faith and Improv

Listen to the Episode Below (31:36)

What can improv teach us about transcending fear?

What can improv teach us about faith?

What personal freedom does knowing improv give us?

How does that personal freedom lead to happiness?

And as always, where there is happiness, health can be found.

Meet my friend Jenny Drescher she teaches improv as way to discover more personal choice.

Check out her website here: http://www.bridgetochoice.com

bridge to choice

bridge to choice

The post Eager to be Healthy – Jenny Drescher – Fear, Faith and Improv appeared first on Michael Eger – Health Coach.

15th International Celiac Disease Symposium

By admin

This is big and very important. This is an annual symposium but will not be back in the U.S. for many years, perhaps 15, if ever. There are two tracks, one for scientists and medical specialists, the other for the rest of us. Try to go, you will not regret it.

We invite you to the ICDS 2013 Chicago
The global conference for everyone who is interested in the study, treatment, and management of celiac disease and gluten-related disorders.

It is with great pleasure that we invite you to the 15th International Celiac Disease Symposium, which will take place on September 22-25, 2013 in Chicago.

While the 15th ICDS meeting will continue to build upon the successes of 40 years of past ICDS scientific programs, the Chicago meeting is designed to address the interests of all of those affected by celiac disease and gluten-related disorders – from physicians and researchers to patients and clinicians to family and friends. The ICDS Chicago will present two distinct interactive educational tracks. The meeting will bring together the world’s top scientists and physicians to discuss the most recent scientific advances in managing and treating celiac disease and gluten-related disorders while a separate clinical forum will be held to further educate dietitians, clinicians, and patients.

However you may be affected by celiac disease or gluten-related disorders, we welcome you to come to Chicago to share your expertise, experiences, opinions, triumphs, and struggles with your colleagues, all with the goal of improving the quality of life for those who are afflicted until the day a cure is found. Register now and come be part of our most memorable symposium to date. You are an important part of this team to help find a cure and we hope you will enhance the meeting with your participation in the ICDS 2013.

The ICDS 2013 is brought to you by The University of Chicago Celiac Disease Center. To learn more about The University of Chicago Celiac Disease Center, please visit our website www.cureceliacdisease.org.
Certificates of Attendance

All attendees to the International Celiac Disease Symposium 2013 in Chicago will receive an official Certificate of Attendance. A Continuing Education Request Form will also be provided should you wish to receive AMA PRA Category 1 CreditTM. There will be a processing charge for the issuance and mailing of CME certificates.
Accreditation

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 17.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses and other health professionals will receive a Certificate of Participation. For information on applicability and acceptance, please consult your professional licensing board. CME fee: $200 for U.S.-based physicians.
Press Passes

A very limited number of press passes will be available for those requesting them upon approval of their media credentials. Eligibility is at the sole discretion of the ICDS Organizing and Scientific Committess. Please email inquiries to icds2013@vista-fr.com. Thank you.

– See more at: http://www.icds2013.org/#sthash.pIwsGp7s.dpuf

    

Top Vitamin D Research of 2014

FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, February 3, 2015

Top Vitamin D Research of 2014

by William B. Grant, PhD

(OMNS Feb 3, 2015) Higher vitamin D blood levels may reduce the risk of many types of disease including autoimmune diseases, cancers, cardiovascular disease, dementia, diabetes mellitus and falls and fractures.

Research into the health effects associated with vitamin D continued to be strong in 2014. The number of publications with vitamin D in the title or abstract listed at pubmed.gov increased from 3,119 in 2011 to 3,919 in 2014. Seven vitamin D researchers (listed after this report) worked together to pick the 20 papers in 2014 that made the most contribution to understanding the health effects of vitamin D in 2014.

Papers are not in priority order, but instead grouped by type of study. For the purpose of this article “vitamin D” in the blood is a measurement of 25-hydroxyvitamin D or 25(OH)D.

Do randomized controlled trials work for vitamin D?

No one refutes the fact that vitamin D is beneficial to the skeletal system. There are many studies (randomized controlled trials [RCT] and also epidemiological) that support this hypothesis. What is at odds is whether or not vitamin D is beneficial to the non-skeletal system. There are many observational (epidemiological, or association) studies that show vitamin D is beneficial, and many RCTs that show it isn’t. Does that mean that vitamin D does not aid in disease prevention? Or does it mean that the RCT model does not work for nutrients?

Randomized Control Trials in 2014

Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease [Martineau, 2014]

A vitamin D trial in the UK in which patients with chronic obstructive pulmonary disease (COPD) were given 120,000 IU vitamin D3 every two months for a year found that vitamin D3 supplementation was protective against moderate or severe exacerbation in those with baseline 25(OH)D concentrations < 50 nmol/L (20 ng/mL) but not for those with concentrations > 50 nmol/L. Vitamin D3 supplementation had no effect on upper respiratory infections. This is consistent with previous RCTs that used high doses at infrequent intervals, every 2 months in this case; however other trials that used an adequate dose given daily have shown reduction in upper respiratory tract infections.

Vitamin D promotes vascular regeneration [Wong, 2014]

This study demonstrated that vitamin D improved cardiovascular disease. The German team investigated this effect several ways. They showed that supplementation with 4000 IU/day of vitamin D3 increased the number of circulating angiogenic myeloid cells, which promote growth and vascular regeneration necessary for a healthy cardiovascular system. A similar result was found in a mouse model, which also demonstrated restoration of impaired angiogenesis (new vessel formation) function. They also examined the mechanisms by which vitamin D acted.

Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. [Spedding, 2014]

This paper reported on a statistical average of many studies of vitamin D RCTs without methodological flaws and found that vitamin D supplementation resulted in a statistically significant improvement in clinical depression. However, the same analysis of vitamin D RCTs with methodological flaws found a statistically significant worsening of depression. The major flaws identified included not increasing 25(OH)D concentrations and not measuring baseline or final 25(OH)D concentrations. Vitamin D supplementation of > 800 IU/d was somewhat favorable in the management of depression.

Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. [Tran, 2014]

A post hoc (conducted after the study was completed) analysis of a vitamin D RCT involving 644 Australian residents aged 60-84 years found a significant reduction in prescribed antibiotics if they were over the age of 70 years and taking 60,000 IU of vitamin D3 monthly compared with the placebo groups. The effect was not significant for those < 70 years of age. This study suggests that taking an average of 2000 IU/day vitamin D3 reduces the risk of infections, most likely respiratory infections, in older adults.

Observational studies of Vitamin D

Observational studies provide some of the strongest evidence to date for beneficial health outcomes related to vitamin D. Observational studies measure vitamin D status and health outcomes for every participant. Blood samples are taken at the time of enrollment and people are followed for several years. Vitamin D is said to be effective if positive health outcomes result.

Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies [Chowdhury, 2014]

This paper was a review of observational and RCT studies that showed a correlation between vitamin D and specific mortality outcomes. One conclusion was that supplementation with vitamin D3 significantly reduces overall mortality among older adults. They used data from 73 cohort studies (849,412 participants) and 22 RCTs (30,716 participants). In the RCTs, all cause mortality rate was reduced by 11% for vitamin D3 supplementation but increased by 4% for vitamin D2 supplementation. In addition, their meta-analysis of cancer-specific incidence and mortality rates comparing those who started in the lowest third of vitamin D blood concentrations against those in the highest third suggests that vitamin D may have a much stronger impact on survival after developing cancer than on reducing the risk of developing cancer to start with.

Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D [Garland, 2014]

An analysis of 32 observational studies found that as 25(OH)D concentrations increased from 13 nmol/L (5 ng/ml) to 90 nmol/L (36 ng/ml) there is a linear reduction in all-cause mortality. At concentrations greater than 90 nmol/L (36 ng/ml), no further improvement was observed. This finding is important in that it did not find any evidence for a U-shaped relationship showing higher risk for both low and high 25(OH)D concentrations as has been reported in some studies. Furthermore, the risk for all-cause mortality rate for those with 25(OH)D concentration < 25 nmol/L (10 ng/mL) was 1.9 compared to that for those with concentrations > 100 nmol/L (40 ng/mL).

Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea [Wang, 2014]

A study in New York found that 25(OH)D concentration and age were the only independent predictors of response to the highly fatal Clostridium difficile-associated diarrhea (CDAD). Subjects with 25(OH)D concentration < 53 nmol/L (21 ng/mL) were 4.75 times more likely to fail to resolve CDAD after 30 days than subjects with 25(OH)D concentrations > 75 nmol/L (30 ng/mL). This is an important finding since CDAD rates are increasing due to antibiotic resistant strains of CD.

Avoidance of sun exposure is a risk factor for all-cause mortality: results from the MISS cohort [Lindqvist, 2014]

An observational study in Sweden involving 29,518 women followed for up to 20 years with 2,545 reported deaths found that the mortality rate for those who avoided sun exposure was approximately twice as high as those who were most exposed to the sun. This difference explained 3% of all deaths and is important since UVB doses in Sweden are generally low and virtually absent for six months of the year. Production of vitamin D may explain most of the differences between sun exposure amounts, although other beneficial effects of solar UV exist, such as release of nitric oxide resulting in reduction of blood pressure, as well as vitamin D-independent effects on the immune system.

25-Hydroxyvitamin D in the range of 20 to 100 ng/ml and incidence of kidney stones [Nguyen, 2014]

GrassrootsHealth (510c3) initiated a voluntary reporting project called D*action. There are over 7,000 in the cohort, of which 2,012 have reported their data for a median of 19 months. In this cohort, there has been no evidence of an association of 25(OH)D and kidney stones. What was a risk factor for kidney stones in this study was high body mass index. This study counters the Women’s Health Initiative study that reported an elevated risk of kidney stones for women taking 400 IU/d vitamin D3 and 1500 mg/d calcium.

Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study [Fedirko, 2014]

An observational study involving 520,000 participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, of which 138 developed hepatocellular carcinoma (HCC) or liver cancer, found that higher levels of 25(OH)D reduced incidence of HCC. Each 10 nmol/L (4 ng/mL) increase in 25(OH)D concentration was associated with a 20% average decrease in risk of HCC. The large number of participants in the study with a very small number of cases indicates the difficulty of demonstrating the beneficial effect of vitamin D for the rare cancers. The authors noted that the result did “not change after adjustment for biomarkers of preexisting liver damage, nor chronic infection with hepatitis B or C viruses.”

Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer [Zgaga, 2014]

A study in Ireland and Scotland involving 1,598 patients with stage I to III colorectal cancer, found that 25(OH)D concentrations (measured approximately 15 weeks after diagnosis of colorectal cancer) were associated with survival rates. Those in the highest third of 25(OH)D concentrations with a median concentration of 51 nmol/L (20 ng/mL) compared to the lowest third with a median concentration of 10 nmol/L (4 ng/mL) had a 32% lower risk of cancer-specific mortality rate and a 30% lower risk of all-cause mortality rate over a ten-year follow-up period. This study provides support for the idea that people diagnosed with cancer should raise their 25(OH)D concentration to above a minimum of 50 nmol/L (20 ng/mL),

Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer [Mohr, 2014]

Two meta-analyses found significantly increased cancer survival rates with higher concentration of 25(OH)D at time of diagnosis. For breast cancer, results from five studies found that those with 25(OH)D concentration of 75 nmol/L (30 ng/mL) had half the 5-20 year mortality rate as those with a lower concentration of 30 nmol/L (12 ng/mL).

Could vitamin D sufficiency improve the survival of colorectal cancer patients? [Mohr, 2014]

In this meta-analysis for colorectal cancer, results from four studies found that those with 25(OH)D concentration of 80 nmol/L (32 ng/mL) had 60% of the 6-20 year mortality rate as those with 45 nmol/L (18 ng/mL).

Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia [Afzal, 2014]

Two papers reported that those with low 25(OH)D concentrations had increased risk of developing vascular dementia and Alzheimer’s disease. This first one is from Denmark. A study involving 418 people followed for 30 years found a 25% increased risk of Alzheimer’s disease and a 22% increased risk of vascular dementia for those with baseline 25(OH)D concentration < 25 nmol/L (10 ng/ml) compared to > 50 nmol/L (20 ng/ml)

Vitamin D and the risk of dementia and Alzheimer disease [Littlejohns, 2014]

In this second paper on dementia and Alzheimer disease, a study in the United States involving 1,658 participants followed for 5.6 years found a 125% increased risk of Alzheimer’s disease for those with severely deficient 25(OH)D levels (< 25 nmol/L (10 ng/mL)), and a 53% increased risk for those with deficient levels ( ≥ 25 to < 50 nmol/L) compared to participants with sufficient concentrations ( ≥ 50 nmol/L (20 ng/mL)).

Pregnancy

Post-hoc comparison of vitamin D status at three time points during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery [Wagner, 2014]

There is considerable interest in the role of vitamin D during pregnancy. In a reanalysis of results from two maternal vitamin D supplementation trials conducted in South Carolina, it was found that: “(1) maternal vitamin D status closest to delivery date was more significantly associated with preterm birth, suggesting that later intervention as a rescue treatment may positively impact the risk of preterm delivery, and (2) a serum concentration of 100 nmol/L (40ng/mL) in the 3rd trimester was associated with a 47% reduction in preterm births.”

Vitamin D in fetal development: Findings from a birth cohort study [Hart, 2014]

A study in Australia compared maternal 25(OH)D concentration at 18 weeks’ pregnancy with outcomes of the children years later. The authors found that “maternal vitamin D deficiency during pregnancy was associated with impaired lung development in 6-year-old offspring, neurocognitive difficulties at age 10, increased risk of eating disorders in adolescence, and lower peak bone mass at 20 years.”

Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis [Hypponen, 2014]

A review of vitamin D supplementation and 25(OH)D concentrations during pregnancy found vitamin D reduces the risk of pre-eclampsia. For 25(OH)D concentration, the combined risk reduction was 48% with higher level circulating vitamin D. For vitamin D RCTs, the combined risk reduction was 34% for vitamin D supplementation vs. a placebo. This review provides further support for the importance of vitamin D supplementation and raising 25(OH)D concentrations during pregnancy.

Randomization

An approach recently being applied to evaluating whether vitamin D can be considered causally linked to health outcomes is Mendelian randomization analysis. In this approach, genetic variants known to be affected by vitamin D are compared to health outcomes. The advantage of this approach is that the results should be independent of baseline 25(OH)D concentrations, which vary over time. The disadvantage is that only a few factors are considered and the most important ones affecting 25(OH)D concentrations may not be included.

Genetically low vitamin D concentrations and increased mortality: mendelian randomization analysis in three large cohorts [Azfal, 2014]

In a study involving 95,766 white participants of Danish descent, genetic variations of DHCR7 (related to vitamin D synthesis) and CYP2R1 (hepatic 25-hydroxylation), which slightly lower plasma 25(OH)D concentrations over the lifetime of the subjects, were examined. As 25(OH)D increased, significant reductions were found for all-cause, cancer and other mortality rates, but not for cardiovascular mortality. These results are interesting, but the method is not strong enough to rule out a protective role of vitamin D in reducing risk of cardiovascular disease. Some regard this approach as particularly weak, since the serum 25(OH)D concentration depends much more in the general population upon solar exposure than upon genes.

Guidelines for optimizing design and analysis of clinical studies of nutrient effects [Heaney, 2014]

Most vitamin D RCTs were based on guidelines designed for pharmaceutical drugs where the only source of the agent is the medication in the trial, and there is a linear dose-response relation between the agent and the outcome. Dr. Heaney asserts that neither assumption is valid for vitamin D trials.

Instead, vitamin D trials should:

  1. Start with an understanding of the 25(OH)D concentration-health outcome relationship. What are we expecting to find?
  2. Measure 25(OH)D concentrations of prospective trial participants and only enroll those with values near the low end of the relation.
  3. Supplement with enough vitamin D to raise 25(OH)D concentrations to near the upper end of the relation.
  4. Measure 25(OH)D concentrations throughout the trial.
  5. Optimize the status of other nutrients related to vitamin D so that vitamin D is the only limiting factor in the response.

Unfortunately, many of the ongoing vitamin D trials have not been designed with these or similar guidelines in mind. As a result, it may be some time before vitamin D RCTs will be able to provide adequate evidence to confirm or refute the findings of observational studies for non-skeletal diseases.

Conclusion

Research on the health benefits of solar UVB exposure and vitamin D continues at a rapid pace. We appear to be in the middle of the golden age of vitamin D research, a period with much progress in understanding the effects of UVB exposure and vitamin D for a large range of health outcomes. We are shifting from discovery to evaluation of previous findings and testing the role of vitamin D in prevention and treatment of various diseases.

While many of the findings from ecological and observational studies are strong, it appears that health systems and policy makers are awaiting results from large on-going RCTs before they accept UVB exposure and vitamin D as valid factors for health. Unfortunately, most of the RCTs currently underway and due to be completed before the end of the decade, including large-scale RCTs in several countries, have not been properly designed, so they may not shed light on vitamin D’s preventive powers. Thus, it may be another decade before the true health benefits of vitamin D and sunlight are accepted. Meanwhile, various types of research will continue and it will be up to individuals and their health care providers to evaluate the available evidence and act accordingly.

For additional information on solar UVB and vitamin D:

http://www.grassrootshealth.net/
http://www.healthresearchforum.org.uk/
http://www.ncbi.nlm.nih.gov/pubmed
http://scholar.google.com/
http://www.sunarc.org/
http://www.vitamindcouncil.org/
http://www.vitamindsociety.org/
http://www.vitamindwiki.com/VitaminDWiki

Other OMNS Press Releases on Vitamin D

This press release is the fifth in the series on vitamin D by the Orthomolecular Medicine News Service. Previous articles:

  1. Vitamin D Stops Cancer; Cuts Risk In Half. American Cancer Society Drags its Feet. Oct. 2, 2008. http://orthomolecular.org/resources/omns/v04n11.shtml
  2. Why You Need More Vitamin D. A Lot More. Sept. 16, 2011. http://orthomolecular.org/resources/omns/v07n07.shtml
  3. Top Vitamin D Papers of 2011, Dosage Recommendations and Clinical Applications. April 10, 2012; http://orthomolecular.org/resources/omns/v08n12.shtml
  4. Vitamin D is Now the Most Popular Vitamin. Jan. 17, 2013. http://orthomolecular.org/resources/omns/v09n01.shtml

Peer review by:

Barbara J Boucher, MD, FRCP, Centre for Diabetes, Blizard Institute, Bart’s & The London School of Medicine & Dentistry, Queen Mary University of London, London, UK.

John J. Cannell, MD, Director, Vitamin D Council, San Luis Obispo, CA, http://www.vitamindcouncil.org/

Cedric F. Garland, DrPH, Professor, Department of Family and Preventive Medicine, Division of Epidemiology, University of California San Diego, La Jolla, CA

William B. Grant, Ph.D., Director, Sunlight, Nutrition and Health Research Center, San Francisco, CA, http://www.sunarc.org/

Michael F. Holick, M.D., Ph.D., Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, and the Vitamin D, Skin, and Bone Research Laboratory, Boston University Medical Center, Boston, MA, http://drholick.com/, Interview at http://www.doctoryourself.com/holick.html

Henry Lahore, Director, http://www.vitaminDwiki.com, Port Townsend, WA

Pawel Pludowski, M.D., Department of Biochemistry, Radioimmunology and Experimental Medicine, The Children’s Memorial Health Institute, Warsaw, Poland

References:

Afzal S, Bojesen SE, Nordestgaard BG. Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement. 2014 May;10(3):296-302.

Afzal S, Brondum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ. 2014 Nov 18;349:g6330. http://www.ncbi.nlm.nih.gov/pubmed/25406188

Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014 Apr 1;348:g1903. http://www.bmj.com/content/348/bmj.g1903?view=long&pmid=24690623

Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, Trepo E, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Kvaskoff M, Kühn T, Lukanova A, Boeing H, Buijsse B, Klinaki E, Tsimakidi C, Naccarati A, Tagliabue G, Panico S, Tumino R, Palli D, Bueno-de-Mesquita HB, Siersema PD, Peters PH, Lund E, Brustad M, Olsen KS, Weiderpass E, Zamora-Ros R, S nchez MJ, Ardanaz E, Amiano P, Navarro C, Quir¢s JR, Werner M, Sund M, Lindkvist B, Malm J, Travis RC, Khaw KT, Stepien M, Scalbert A, Romieu I, Lagiou P, Riboli E, Jenab M. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology. 2014 Oct;60(4):1222-30. http://www.ncbi.nlm.nih.gov/pubmed/24644045

Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, Baggerly L, Hofflich H, Ramsdell J, Zeng K, Heaney RP.Meta-analysis of all-cause mortality according to serum 25-hydroxyvitamin D. Am J Pub Health. 2014 Aug;104(8):e43-50. http://www.ncbi.nlm.nih.gov/pubmed/24922127

Hart PH, Lucas RM, Walsh JP, Zosky GR, Whitehouse AJ, Zhu K, Allen KL, Kusel MM, Anderson D, Mountain JA. Vitamin D in fetal development: Findings from a birth cohort study. Pediatrics. 2015 Jan;135(1):e167-73. http://www.ncbi.nlm.nih.gov/pubmed/25511121

Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014 Jan;72(1):48-54. http://www.ncbi.nlm.nih.gov/pubmed/24330136

Hyppönen E, Cavadino A, Williams D, Fraser A, Vereczkey A, Fraser WD, B nhidy F, Lawlor D, Czeizel AE. Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Ann NutrMetab. 2013;63(4):331-40. (published in 2014) http://www.ncbi.nlm.nih.gov/pubmed/24603503

Lindqvist PG, Epstein E, Landin-Olsson M, Ingvar C, Nielsen K, Stenbeck M, Olsson H. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the MISS cohort. J Intern Med. 2014 Jul;276(1):77-86. http://www.ncbi.nlm.nih.gov/pubmed/24697969

Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller LH, Lang KM, Lopez OL, Kos K, Soni M, Llewellyn DJ. Vitamin D and the risk of dementia and Alzheimer disease.Neurology. 2014 Sep 2;83(10):920-8.

Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Islam K, McLaughlin D, Bhowmik A, Timms PM, Rajakulasingam RK, Rowe M, Venton TR, Choudhury AB, Simcock DE, Wilks M, Degun A, Sadique Z, Monteiro WR, Corrigan CJ, Hawrylowicz CM, Griffiths CJ. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2014 Dec 1. pii: S2213-2600(14)70255-3. doi: 10.1016/S2213-2600(14)70255-3. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25476069

Mohr SB, Gorham ED, Kim J, Hofflich H, Cuomo RE, Garland CF. Could vitamin D sufficiency improve the survival of colorectal cancer patients? J Steroid Biochem Mol Biol. 2014 Dec 19. pii: S0960-0760(14)00316-1. doi: 10.1016/j.jsbmb.2014.12.010. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25533386

Mohr SB, Gorham ED, Kim J, Hofflich H, Garland CF. Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer. Anticancer Res. 2014 Mar;34(3):1163-6. http://www.ncbi.nlm.nih.gov/pubmed/24596354

Nguyen S, Baggerly L, French C, Heaney RP, Gorham ED, Garland CF. 25-Hydroxyvitamin D in the range of 20 to 100 ng/mL and incidence of kidney stones. Am J Public Health. 2014 Sep;104(9):1783-7. http://www.ncbi.nlm.nih.gov/pubmed/24134366

Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014 Apr 11;6(4):1501-18. http://www.ncbi.nlm.nih.gov/pubmed/24732019

Tran B, Armstrong BK, Ebeling PR, English DR, Kimlin MG, van der Pols JC, Venn A, Gebski V, Whiteman DC, Webb PM, Neale RE. Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial. Am J Clin Nutr. 2014 Jan;99(1):156-61. http://www.ncbi.nlm.nih.gov/pubmed/24108783

Wagner CL, Baggerly C, McDonnell SL, Baggerly L, Hamilton SA, Winkler J, Warner G, Rodriguez C, Shary JR, Smith PG, Hollis BW. Post-hoc comparison of vitamin D status at three time points during pregnancy demonstrates lower risk of preterm birth with higher vitamin D closer to delivery. J Steroid Biochem Mol Biol. 2014 Nov 13. pii: S0960-0760(14)00268-4. doi: 10.1016/j.jsbmb.2014.11.013. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/25448734

Wang WJ, Gray S, Sison C, Arramraju S, John BK, Hussain SA, Kim SH, Mehta P, Rubin M. Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea. Therap Adv Gastroenterol. 2014 Jan;7(1):14-9. http://www.ncbi.nlm.nih.gov/pubmed/24381644

Wong MS, Leisegang MS, Kruse C, Vogel J, Schürmann C, Dehne N, Weigert A, Herrmann E, Brüne B, Shah AM, Steinhilber D, Offermanns S, Carmeliet G, Badenhoop K, Schröder K, Brandes RP. Vitamin D promotes vascular regeneration. Circulation. 2014 Sep 16;130(12):976-86. http://www.ncbi.nlm.nih.gov/pubmed/25015343

Zgaga L, Theodoratou E, Farrington SM, Din FV, Ooi LY, Glodzik D, Johnston S, Tenesa A, Campbell H, Dunlop MG. Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 2014 Aug 10;32(23):2430-9. http://www.ncbi.nlm.nih.gov/pubmed/25002714

Nutritional Medicine is Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Ian Brighthope, M.D. (Australia)
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Michael Janson, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Stuart Lindsey, Pharm.D. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Erik Paterson, M.D. (Canada)
W. Todd Penberthy, Ph.D. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Robert G. Smith, Ph.D. (USA)
Jagan Nathan Vamanan, M.D. (India)
Atsuo Yanagisawa, M.D., Ph.D. (Japan)

Andrew W. Saul, Ph.D. (USA), Editor and contact person. Email: omns@orthomolecular.org This is a comments-only address; OMNS is unable to respond to individual reader emails. However, readers are encouraged to write in with their viewpoints. Reader comments become the property of OMNS and may or may not be used for publication.

Celiac and Gluten Free Support Group meet up

By admin

CELIAC & GLUTEN FREE
SUPPORT GROUP OF
WESTERN MASSACHUSETTS
September Meeting: 17 Sep 2014, 7 p.m.
N.B. THIS IS A NEW Location CHANGE
Sylvester’s Restaurant, 111 Pleasant St., Northampton
Come early for open networking
GLUTEN FREE EXPO coming to Springfield in October
Free admission for volunteers. Details at this meeting
Also, late breaking news and information about
gluten intolerance and celiac disease
This will be a worthwhile evening of interactive discovery, discussion, and helpful information
For questions call Bruce Homstead, MS, RDN, LDN: homsteadhealth@live.com 413-527-7524

Read more here:: The Gluten Warrior

      

Deepak Chopra’s “Future of GOD”

By amy

Deepak Chopra is an author and a New York Times bestseller. He has authored eighty books that have been translated into over forty-three different languages. His books fall into both the fiction and non-fiction categories. Time magazine heralds Chopra as one of the top 100 heroes and icons of the 21st century and gives him credit as “the poet profit of alternative medicine…”

Deepak Chopra is on a mission to teach the world how to connect back with GOD. Chopra feels that the world has lost that “link” to our higher power. We have put up walls and road blocks in our lives that will not allow us to connect with GOD on a deeper and more spiritual level.

How is your relationship with GOD or do you even possess or desire to have a relationship with him? This was definitely an amazing event and I wish I could have been in the presence of the crowd as he spoke to them. In the end, Deepak laid out a road map to help people connect back with GOD.

There are four main ways that Deepak spoke of, that can assist us in finding our way. You have to first, discover the “inner you”. You can do this by understanding 4 main principles:

1. Expanding your awareness
2. Meditation
3. Prayer
4. Self-awareness

These four principles are a foundation to begin unlocking your spiritual awareness. Check out this article and let’s talk about it…. Tell me what you think!

http://www.huffingtonpost.com/alex-kip/deepak-chopras-future-of-_b_56482…

Read more here: Choose Evolution

    

THE JOY OF SOY

Soybeans are considered to be a source of complete protein. A complete protein is one that contains significant amounts of all the essential amino acids that must be provided to the human body because of the body’s inability to synthesize them. For this reason, soy is a good source of protein, amongst many others, for people who want to reduce the amount of meat they eat. Because meat contain more fat, especially saturated fat.

NUTRIENTS IN SOY    

Good source of enriched Calcium and Vitamin B12

  • Low in fat with no cholesterol
  • Contains essential heart friendly omega-3 fats
  • Temph, soy flour and texture soy protein are excellent source of fiber.
  • Complete protein, containing all the amino acids essential to human nutrition
  • Provides important minerals such as calcium, magnesium, iron and selenium
  • Rich in probiotics in the form of fermented soy products, such as miso, tempeh, and soy yogurt.
  • Contains isoflavones which are beneficial in reducing risk of various cancers, heart disease and osteoporosis
  • Whole soy foods such as tofu and tempeh form a nutrient rich alternative to meat
  • Soybeans contain high levels of several health beneficial compounds including tocopherols which have antioxidant properties. Tocopherols could play a role in cardiovascular disease and cancer prevention.

SOY MILK

Many type of soy milk in the market are processed form. These soy milk are not made with real soybeans. Fresh soy milk is best. Choose whole soy bean milk. Avoid soy milk made from soy protein or soy isolate. These soy milk will contain additives. It helps to extend the shelf-life. And also, check the label for sugar content. It contain brown rice or evaporated cane juice , avoid it. Because , these kind of soy milk contain more calories than a cup of skim milk. Fresh soy milk available at certain health food stores.

FERMENTED SOY FOODS IS GOOD

  • Edamame, or young green soybeans, are a great source of protein. Just one half-cup serving of edamame provides 8 grams of protein. They steam in minutes and are perfect to eat as a snack or add to a salad. 
  • Other whole soy options include varieties like tempeh, miso and natto, made of fermented cooked soybeans. The fermentation allows nutrients to be more easily absorbed into the body, as fermented foods are brimming with good-for-your-belly probiotics, which help keep our gut flora healthy. 
  • Tempeh is a high-protein source of nutrients like vitamins B2, B6, and B3, and minerals magnesium, copper, iron, manganese, and phosphorous. In addition, it is a good source of monounsaturated fats.
  • Miso is rich in vitamin B12, which is a power player when it comes to metabolizing fats and carbohydrates. Miso pastes are available in supermarkets. Be sure to purchase the low-sodium variety.
  • Natto is a sticky paste made by adding healthy bacteria to lightly cooked soybeans and fermenting. Natto is a powerful food rich in the enzyme nattokinase, which has been shown to reduce the risk of blood clots and help break up the plaque associated with Alzheimer’s disease. In Japan, people routinely enjoy natto for breakfast, served on top of rice with an egg split over it.

You can find fermented soy foods at health food stories, Asian markets, or online.

 PROCESSED SOY FOODS AFFECTS THE HEALTH

The physical properties of foods are artificially altered in a way that makes them dangerous

  • Soybean oil is one of the major processed oil that is used to frying  commercial food items. The fatty acids in soybeans are mostly Omega-6 polyunsaturated fats. Omega-6s in the diet can lead to inflammation and health issues. so, avoid soybean oil and other vegetable oil high in Omega-6 and processed foods that contain it.
  • When using processed soy foods regularly women’s have some problems like stopped menstruating, stomach upset, moody and bloated, Endocrine disruption and digestive problems
  • Processed soy milk , cheese contain chemicals and devoid of nutrients. Processing decrease the nutrient content like calcium, fiber content. Tofu and soymilk contain little fiber.
  • In Japan and china have a lower incidence of breast and prostate cancer due to a traditional diet that includes soy than people in the United States. But Asians include small amounts about nine grams a day mainly fermented soy products such as miso, natto, tempeh and some tofu.
  • Fermenting soy creates health promoting probiotics, the good bacteria. It helps to maintain digestive and overall wellness. But in United States processed soy snacks or shakes can contain over 20 grams of non-fermented soy protein in one serving.
  • In soy formula the estrogen in soy will affect the hormonal development, brain, reproductive systems and thyroid of the children.
  • It contain large amount of manganese and it create the deficit disorder and neurotoxicity in Infants. The Israeli health ministry recently issued and advisory stating that infant should avoid soy formula.

 SOY CONTAIN ANTI NUTRIENTS – IS IT SAFE TO EAT?

For human consumption, soybeans must be cooked with “wet” heat to destroy the trypsin inhibitors. Raw soybeans are toxic to humans and animals.

 BREAST CANCER

Some of the soy based studies in related to disease prevention is controversial. But, evidences in human shows that soy is safe for women to consume. And research suggest that consuming soy during puberty reduces risk for breast cancer in later life.

REPRODUCTION

Research shows that isoflavones have no effect on sperm quality or testosterone levels in men. And , soy does not prevent ovaluation in women. There is no evidence of reproductive problems in populations with regular soy foods consumption.

THYROID

Soy does not affect thyroid function in healthy adults. Many foods including soy ,broccoli, and millet contain goitrogens that interfere with thyroid gland. Most people can eat these foods regularly without problems. Problems occur in people who have low intake of the iodine which is needed for mineral thyroid function. So, people who have thyroid problem control the soy foods.

MINERAL ABSORPTION

Consuming soy foods  will leads to poor mineral status is not founded. When you take soy foods you should take other mineral and vitamin sources like iron , zinc and vitamin C.

Studies have been raise questions about the safety of soy but the bulk of the evidence shows that it is safe.

  Soy is rich in nutrients like calcium and protein and it is good for health. But in which form we take is very important. Fermented soy foods helps to improve our gut function and digestion. Nutrients in fermented soy is easily absorbed in our body. So , Please try fermented soy foods.  It is very important to avoid uncooked  and processed soy foods. Uncooked soy equal to poison. processed soy creates various  health problems. So, avoid using processed soy milk and cheese. 

  So,  Enjoy natural, organically grown, unprocessed soy foods.

I invite you all to become an Healthy Bee at http://eagertobehealthy.com/podcast

The Benefits of Meditation

By amy

Meditating is an ultimate stress reliever and it is extremely therapeutic for the mind, body and soul. It is the process of training your mind to clear itself, completely, of all thoughts. In an article that I read recently, it stated:

” It’s extremely difficult for a beginner to sit for hours and think of nothing or have an “empty mind.” But in general, the easiest way to begin meditating is by focusing on the breath — an example of one of the most common approaches to meditation: concentration.”

With that being said, I have recorded several amazing meditations for you to enjoy, for purchase and download. You can take these meditations anywhere and listen to them on your own time. Learning to meditate takes time and patience. It is a good practice to start with focusing on a single point. Some experts say that focusing on your breath by slowly breathing in and out; clearing all other thoughts is a good way to start.

Some of the benefits of meditation are:

Lower blood pressure
Better sleep
Improved blood circulation
Less Stress
Slower respiratory rate
Less nervousness
Lower blood cortisol levels
Better awareness if your surroundings

The most amazing benefit of all is the freeing of the mind and attachment to material things. For more information on the benefits of meditation, click on the link below!

http://life.gaiam.com/article/meditation-101-techniques-benefits-beginne…

Most importantly, check out these easy to follow meditations from me, Amy D.! You will be so glad that you did! Enjoy!!

http://www.choosevolution.com/content/products-activate-your-awareness

Let me know what you think! #choosevolution

Read more here: Choose Evolution

    

1 2 3 4 5

All orders fulfilled by Amazon.com